Molecular Biology Enzymes Market
Molecular Biology Enzymes Market Forecasts to 2030 - Global Analysis By Product (Enzymes, Kits & Reagents, DNA Extraction, Isothermal Amplification and Other Products), Application, End User and By Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $20.6 BN |
Projected Year Value (2030) |
US $59.0 BN |
CAGR (2023 - 2030) |
16.2% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Molecular Biology Enzymes Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. In molecular biology, enzymes are specialized proteins that function as catalysts to quicken and ease metabolic processes in living things. They function by reducing the activation energy needed for a certain chemical reaction to take place, which speeds up these reactions without consuming any resources or changing them in the process. Because they are made to catalyze certain processes or groups of related events, enzymes are extremely specialized.
According to a survey conducted by the World Health Organization, approximately 12,368 individuals were positive for influenza viruses, of which 8,423 (68.1%) were typed as influenza A and 3,945 (31.9%) as influenza B.
Market Dynamics:
Driver:
Increasing amount of genomic projects
The genesis and progression of illnesses such immune system disorders, metabolic diseases, cancer, and inborn genetic disorders are significantly influenced by gene mutations. Research in a number of areas, including illness treatment, customized medicine, and microbial genetics, is advanced by the growing number of genome projects being undertaken worldwide and the declining costs associated with genetic analysis. The market is anticipated to be driven by these procedures, which call for the employment of a variety of enzymes and reagents.
Restraint:
Limited reimbursements for genetic testing
Reimbursement limitations limit the availability of specific molecular biology enzymes needed for genetic testing. Good enzymes can be costly; if reimbursements do not cover the entire cost, labs or research centers may choose to use less expensive substitutes, which may reduce test accuracy or efficiency. Research and development attempts to create newer, more efficient enzymes are hampered by limited reimbursement, which is hampering the growth of the market.
Opportunity:
Rising advancements
The need for specialized enzymes is driven by ongoing advances in molecular biology research as well as the necessity of enzymes for a variety of applications in industries including proteomics, genomics, and recombinant DNA technology. Additionally, advances in recombinant DNA, protein engineering, and enzyme engineering result in the production of new enzymes with enhanced characteristics, which propels market expansion.
Threat:
Regulatory hurdles
Strict regulatory oversight is frequently imposed on enzymes utilized in molecular biology, particularly when these enzymes are used in clinical or medical contexts. Ensuring compliance and meeting regulatory requirements may be costly and time-consuming procedures. It can be costly and time-consuming to comply with regulatory requirements and go through the approval procedures for new enzymes or changes. This is the main factor limiting the market's expansion.
Covid-19 Impact:
The focus of research goals moved significantly from other fields of molecular biology study to COVID-19-related investigations. This has an effect on the market for certain enzyme varieties utilized in various studies and applications. The supply chain experienced major interruptions as a result of manpower constraints, transit restrictions, and lockdowns. This has an impact on the availability of various lab supplies including enzymes used in molecular biology.
The kits & reagents segment is expected to be the largest during the forecast period
The kits & reagents segment is expected to be the largest during the forecast period. This can be attributed to the vast availability of these products in the market space, novel developments, and continuous product launches from key players. Enzymes are expected to rise at the quickest rate over the projection period due to the ongoing development of cloning technology as a standard laboratory procedure and the expanding field of molecular biology. This has allowed the manufacturers and suppliers to provide multiple enzymes for nucleic acid manipulation.
The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period
The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period. This can be attributed to the widespread adoption of molecular biology products that facilitate workflow. The convenience and effectiveness of these goods during the pharma and biotech businesses' research for drug candidates, customized medicine, or diagnostics enhances their offers and, as a result, increases revenues. In the upcoming years, the market will be driven by the widespread adoption of molecular technologies by businesses throughout the R&D and clinical trials phases.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to increase in research funds in clinical & translational research and surge in number of biotechnology & pharmaceutical companies in nations. Research on preventive and treatment options is growing due to the prevalence of chronic illnesses in all age groups and the ubiquity of cancer in the community. The presence of well-established players ease of adoption of new technologies are considered to be the major factors fueling revenue generation in this region.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period the presence of bio-clusters in the nations. Manufacturers of molecular biology have found great development potential due to the deficient healthcare systems, large population, increased need for focused therapeutics, and quick economic expansion. Further encouraging western corporations to introduce new goods and win market dominance in these countries is the rising spending power of these nations, which in turn has increased market revenue.
Key players in the market
Some of the key players in Molecular Biology Enzymes market include Illumina, Inc., Merck KGAA, Bioline Technologies, Promega Corporation, Rockland Immunochemicals, Qiagen, Agilent Technologies, Inc., Jena Bioscience GmbH, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited and Bausch Health Companies Inc.
Key Developments:
In October 2022, Illumina Inc. announced strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise.
In September 2021, Thermo Fisher Scientific has announced the launch of its fully-automated analyzers specifically designed for enzyme assay applications. The systems combine hardware and new custom-designed software to deliver fully automated incubation settings, reagent additions and precise measurement calculations, all at the touch of a button.
Products Covered:
• Enzymes
• Kits & Reagents
• DNA Extraction
• Isothermal Amplification
• Other Products
Applications Covered:
•Polymerase Chain Reaction (PCR)
• Epigenetics
• Cloning
• Sequencing
• Restriction Digestion
• Synthetic Biology
• Other Applications
End Users Covered:
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centres
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Molecular Biology Enzymes Market, By Product
5.1 Introduction
5.2 Enzymes
5.2.1 Polymerases
5.2.2 Restriction Endonucleases
5.2.3 Reverse Transcriptases
5.2.4 Ligases
5.2.5 Phosphatases
5.2.6 Proteases and Proteinases
5.3 Kits & Reagents
5.3.1 Lyophilisable and Air Dryable
5.3.2 Next-Generation Sequencing
5.3.3 Polymerase Chain Reaction
5.4 DNA Extraction
5.5 Isothermal Amplification
5.6 Other Products
6 Global Molecular Biology Enzymes Market, By Application
6.1 Introduction
6.2 Epigenetics
6.3 Cloning
6.4 Sequencing
6.5 Restriction Digestion
6.6 Synthetic Biology
6.7 Other Applications
7 Global Molecular Biology Enzymes Market, By End User
7.1 Introduction
7.2 Academic & Research Institutes
7.3 Pharmaceutical & Biotechnology Companies
7.4 Hospitals & Diagnostic Centres
7.5 Other End Users
8 Global Molecular Biology Enzymes Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Illumina, Inc.
10.2 Merck KGAA
10.3 Bioline Technologies
10.4 Promega Corporation
10.5 Rockland Immunochemicals
10.6 Qiagen
10.7 Agilent Technologies, Inc.
10.8 Jena Bioscience GmbH
10.9 Thermo Fisher Scientific, Inc.
10.10 F. Hoffmann-La Roche Ltd.
10.11 Bio-Rad Laboratories, Inc.
10.12 Takara Bio, Inc.
10.13 LGC Limited
10.14 Bausch Health Companies Inc.
List of Tables
1 Global Molecular Biology Enzymes Market Outlook, By Region (2021-2030) ($MN)
2 Global Molecular Biology Enzymes Market Outlook, By Product (2021-2030) ($MN)
3 Global Molecular Biology Enzymes Market Outlook, By Enzymes (2021-2030) ($MN)
4 Global Molecular Biology Enzymes Market Outlook, By Polymerases (2021-2030) ($MN)
5 Global Molecular Biology Enzymes Market Outlook, By Restriction Endonucleases (2021-2030) ($MN)
6 Global Molecular Biology Enzymes Market Outlook, By Reverse Transcriptases (2021-2030) ($MN)
7 Global Molecular Biology Enzymes Market Outlook, By Ligases (2021-2030) ($MN)
8 Global Molecular Biology Enzymes Market Outlook, By Phosphatases (2021-2030) ($MN)
9 Global Molecular Biology Enzymes Market Outlook, By Proteases and Proteinases (2021-2030) ($MN)
10 Global Molecular Biology Enzymes Market Outlook, By Kits & Reagents (2021-2030) ($MN)
11 Global Molecular Biology Enzymes Market Outlook, By Lyophilisable and Air Dryable (2021-2030) ($MN)
12 Global Molecular Biology Enzymes Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
13 Global Molecular Biology Enzymes Market Outlook, By DNA Extraction (2021-2030) ($MN)
14 Global Molecular Biology Enzymes Market Outlook, By Isothermal Amplification (2021-2030) ($MN)
15 Global Molecular Biology Enzymes Market Outlook, By Other Products (2021-2030) ($MN)
16 Global Molecular Biology Enzymes Market Outlook, By Application (2021-2030) ($MN)
17 Global Molecular Biology Enzymes Market Outlook, By Polymerase Chain Reaction (2021-2030) ($MN)
18 Global Molecular Biology Enzymes Market Outlook, By Epigenetics (2021-2030) ($MN)
19 Global Molecular Biology Enzymes Market Outlook, By Cloning (2021-2030) ($MN)
20 Global Molecular Biology Enzymes Market Outlook, By Sequencing (2021-2030) ($MN)
21 Global Molecular Biology Enzymes Market Outlook, By Restriction Digestion (2021-2030) ($MN)
22 Global Molecular Biology Enzymes Market Outlook, By Synthetic Biology (2021-2030) ($MN)
23 Global Molecular Biology Enzymes Market Outlook, By Other Applications (2021-2030) ($MN)
24 Global Molecular Biology Enzymes Market Outlook, By End User (2021-2030) ($MN)
25 Global Molecular Biology Enzymes Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
26 Global Molecular Biology Enzymes Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
27 Global Molecular Biology Enzymes Market Outlook, By Hospitals & Diagnostic Centres (2021-2030) ($MN)
28 Global Molecular Biology Enzymes Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.